filtration - Bioprocess Development Forum

Articles BioPharma BioPharma BioPharma BioPharma Downstream Downstream Downstream Downstream Events Multimedia Q&A Regulatory Regulatory Regulatory Regulatory Upstream Upstream Upstream Upstream

January 10, 2025

Free workshops: manufacturing high-concentration biologics – Feb 11, Mar 13, or Mar 26

CytivaManufacturing high-concentration biologics: Challenges and solutions Join us at one of the workshops Topics include:…

Jeanne Linke

Articles Downstream

December 12, 2024

Evaluation of mAb transmission through Supor™ Prime membrane filters

Cytiva Drug formulations in the market are changing with the share of subcutaneous administration over…

Jeanne Linke

Articles Downstream

December 2, 2024

Supor™ Prime filter performance with high-risk fluids

CytivaAlthough bacterial penetration of sterilizing-grade filters rarely occurs, it still remains an industry-wide challenge, with…

Jeanne Linke

Articles Downstream Downstream Events Upstream Upstream

November 15, 2024

ÄKTA readyflux™ virtual demonstration on December 4, 2024

CytivaWhat features make a filtration system especially useful for pilot- and small-scale manufacturing? How much…

Jeanne Linke

Articles Downstream Downstream Multimedia

October 5, 2024

Quick guide: setting up mAb downstream processes

This one-page visual guide puts techniques, products, and solutions for downstream processes in one place:…

Ross Burns

Articles Downstream Downstream Multimedia

September 19, 2024

Printed poster for bioprocess filters for your lab wall

Use this printed guide to quickly select the right filters for depth filtration, tangential flow…

Ross Burns

Articles BioPharma Downstream

September 5, 2024

Developing a sterilizing grade filter for high concentration biologics

With the development and manufacture of subcutaneous biologics come challenges in the sterilizing or bioburden…

Ross Burns

Articles Downstream

August 22, 2024

Introducing Supor Prime Filters: A Filtration Solution for High-Concentration Therapies

The advent of new therapies brings new manufacturing challenges for biopharma. As an example, subcutaneous…

Ross Burns

Articles Downstream Downstream Multimedia

August 22, 2024

Download the infographic about viral vector manufacturing

Crafting a downstream viral vector process that's budget-friendly and GMP-ready is no small feat. But…

Ross Burns

Articles Downstream

August 22, 2024

Regulatory considerations for virus filtration process development

Virus filtration is a robust mechanism to ensure virus safety of biotherapeutic manufacturing processes and…

Ross Burns